130 years of Philips innovation, collaboration, and social responsibility
May 12 2021 - 4:00AM
130 years of Philips innovation, collaboration, and social
responsibility
May 12, 2021
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
celebrated 130 years of innovation, collaboration, and social
responsibility. During its rich history since being founded on May
15, 1891, in Eindhoven in the Netherlands, the company has
continuously reinvented itself to remain relevant to society.
Today, Philips is a leading health technology company with a
purpose to improve the lives of 2.5 billion people a year by 2030
through meaningful innovation.
“The company’s 130th anniversary is a celebration of the
continuous innovation journey that has enabled Philips to
positively impact the lives of so many people around the globe,”
said Frans van Houten, CEO of Royal Philips. “It’s also about
looking forward – continuing to innovate, collaborate and live up
to the highest standards of doing business responsibly and
sustainably. We will continue to team up with innovators, experts
and society to help create new ground-breaking solutions to today’s
healthcare challenges.”
New sculpture of Gerard PhilipsAs a tribute to
130 years of innovation and collaboration, Philips will offer an
artwork of Gerard Philips, who together with his father Frederik
Philips, founded the company. The sculpture will be unveiled in
Eindhoven city center at a newly developed public location. Gerard
later also founded Philips’ research laboratories in Eindhoven, the
strong foundation of Philips’ global innovation strength today,
which currently includes five innovation hubs and multiple
innovation and manufacturing sites. Philips spends EUR 1.8 billion
annually on R&D to fuel the company’s growth and intellectual
property, which comprises approx. 59,000 patent rights and 31,000
trademarks.
Innovation and entrepreneurship Philips’ entry
into health technology took place during the First World War when
it applied the skills it had developed for manufacturing lightbulbs
to repairing, and subsequently manufacturing, X-ray tubes for
diagnostic imaging, rapidly innovating their design to minimize
X-ray exposure and improve image quality. Since then, Philips has
innovated virtually every major medical imaging modality from
ultrasound to MRI and CT systems.
Philips’ current innovations span the health continuum from
healthy living and disease prevention to diagnosis, treatment, and
care in the home. By bringing together devices, systems, software,
artificial intelligence (AI) and advanced analytics, the company
today develops intelligent solutions that help consumers around the
world to live healthy lifestyles and enable healthcare providers to
deliver on the quadruple aim: enhancing the patient experience,
improving health outcomes, lowering the cost of care, and improving
the work life of care providers.
Recent examples include:
- Philips’ AI Workflow Suite – IntelliSpace – a solution for
AI-assisted radiology workflows, automatically distributing data to
AI applications to increase efficiency/productivity, reduce staff
overload, and enhance the patient experience.
- Philips Image Guided Therapy System – Azurion – accelerating
the move from open surgery to minimally-invasive surgery, enabling
patients to recover faster and hospital systems to reduce
costs.
- Philips’ eICU telemedicine program and wearable biosensor –
enabling patients to be expertly monitored 24/7 inside and outside
hospitals.
- AI-powered personal health innovations, such as Philips
Sonicare Power Toothbrush 9900 Series Prestige with SenseIQ and its
advanced Shaver 9000 Series with SkinIQ technology, are driving the
personalization of consumer health through solutions that adapt to
an individual user’s unique behavior and needs.
Collaboration and partnershipsIn an ever more
complex and interconnected world, meaningful innovation in
healthcare also requires co-creation through partnerships and
collaborations with leading clinical researchers and care
providers. Key examples of leading institutes that Philips
collaborates with include:
- University Medical Center Utrecht (The Netherlands) - advancing
precision diagnosis through breakthrough quantitative MRI
technology – MR STAT.
- Dana-Farber Cancer Institute (Boston, U.S.) - co-developing
Philips Oncology Pathways powered by Dana-Farber to provide
clinicians worldwide with access to best-practice and personalized
care recommendations for patients, based on the latest
scientific advances.
- Singapore General Hospital (Singapore) - leveraging Philips
Pathology Suite – IntelliSite – in the development of AI-based
tools
- U.S. Department of Veterans Affairs (US), expanding the VA’s
critical tele-critical care program by creating the world’s largest
system comprising more than 1,700 sites and serving nearly nine
million veterans each year. The program aims to provide veterans
with remote access to intensive care expertise, including research
into technologies that can better support veterans.
- MONET Technologies Inc. (Japan) - Philips, MONET Technologies
and Ina City are addressing the rapidly aging population and
shortage of medical facilities and healthcare professionals in
Japan through a mobile healthcare vehicle concept equipped with
connected care technologies.
Philips also enters into long-term strategic partnerships with
hospitals and hospital groups that are characterized by new
business models and the move from one-time transactions to
continuous relationships aimed at offering hospitals a holistic
solution that addresses their clinical, operational, and business
needs. For example, with:
- Klinikum Stuttgart Hospital (Stuttgart, Germany) – a 10-year
innovation partnership to keep the hospital equipped with the
latest state-of-the-art diagnostic imaging, informatics, and
connected care solutions.
- Flevo Hospital (Almere, The Netherlands) – a 10-year strategic
partnership agreement to continuously innovate and optimize patient
care in the Almere region of the Netherlands.
Social responsibilityPhilips’ recognition of
its social responsibility goes as far back as 1932, when it started
screening its staff, and eventually the whole population of
Eindhoven (the Dutch city where the company was founded) for
tuberculosis. In the 1990s Philips helped to pioneer the Dutch
national breast cancer screening program.
Today, the company’s Environmental, Social and Corporate
Governance (ESG) commitments are enshrined in its new 5-year ESG
targets and strategic plans. Philips is already carbon neutral in
its operations and is set to further reduce its CO2 emissions in
line with 1.5°C global warming and source 75% of its total energy
consumption from renewables. The company also aims to increase
revenue from circular economy solutions to 25% of sales by
2025.
As part of its target to improve the lives of 2.5 billion people
a year by 2030, Philips is committed to improving access to care
for 400 million people in underserved communities. In collaboration
with key strategic partners and the Philips Foundation, it is
enabling care in resource constrained settings, for example, by
putting portable ultrasound solutions into the hands of trained
midwives at primary care facilities in Kenya, and establishing
hospital-based cardiology centers in regional cities across
India.
For details of the above innovations, collaborations,
partnerships and ESG targets, click here.
For more information on Philips history, click here or visit the
Philips Museum website.
For further information, please contact:
Joost MalthaPhilips Global Press OfficeTel.: +31 6 10 55 81
16E-mail: joost.maltha@philips.com
Tommie DijstelbloemPhilips BeneluxTel.: +31 6 19 28 83 20E-Mail:
tommie.dijstelbloem@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 17.3 billion and
employs approximately 77,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Press Backgrounder - Innovation and entrepreneurship,
collaboration and strong commitment to ESG goals power Philips'
continued relevance to society as it reaches its 130th
anniversary
- Philips Sonicare Power Toothbrush 9900 Series Prestige with
SenseIQ
- Philips’ AI Workflow Suite – IntelliSpace –
- Philips Image Guided Therapy System – Azurion –
- Philips eICU program
- Early Philips diagnostic X-ray solution used in 1933 in the
Netherlands
- Screening Philips staff for or tuberculosis in 1951 in the
Netherlands
- To celebrate 130 years of Philips Frans van Houten, CEO of
Philips, opened the Euronext Amsterdam Stock Exchange this
morning
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024